1011 related articles for article (PubMed ID: 33181336)
1. Emerging potential of cannabidiol in reversing proteinopathies.
Dash R; Ali MC; Jahan I; Munni YA; Mitra S; Hannan MA; Timalsina B; Oktaviani DF; Choi HJ; Moon IS
Ageing Res Rev; 2021 Jan; 65():101209. PubMed ID: 33181336
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective potential of cannabidiol: Molecular mechanisms and clinical implications.
Tambe SM; Mali S; Amin PD; Oliveira M
J Integr Med; 2023 May; 21(3):236-244. PubMed ID: 36973157
[TBL] [Abstract][Full Text] [Related]
3. Potential roles of natural products in the targeting of proteinopathic neurodegenerative diseases.
Dash R; Jahan I; Ali MC; Mitra S; Munni YA; Timalsina B; Hannan MA; Moon IS
Neurochem Int; 2021 May; 145():105011. PubMed ID: 33711400
[TBL] [Abstract][Full Text] [Related]
4. Neurological Aspects of Medical Use of Cannabidiol.
Mannucci C; Navarra M; Calapai F; Spagnolo EV; Busardò FP; Cas RD; Ippolito FM; Calapai G
CNS Neurol Disord Drug Targets; 2017; 16(5):541-553. PubMed ID: 28412918
[TBL] [Abstract][Full Text] [Related]
5. Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders.
Yousaf M; Chang D; Liu Y; Liu T; Zhou X
Molecules; 2022 Aug; 27(15):. PubMed ID: 35956911
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic applicability of cannabidiol and other phytocannabinoids in epilepsy, multiple sclerosis and Parkinson's disease and in comorbidity with psychiatric disorders.
de Fátima Dos Santos Sampaio M; de Paiva YB; Sampaio TB; Pereira MG; Coimbra NC
Basic Clin Pharmacol Toxicol; 2024 May; 134(5):574-601. PubMed ID: 38477419
[TBL] [Abstract][Full Text] [Related]
7. The impact of proteostasis dysfunction secondary to environmental and genetic causes on neurodegenerative diseases progression and potential therapeutic intervention.
Elmatboly AM; Sherif AM; Deeb DA; Benmelouka A; Bin-Jumah MN; Aleya L; Abdel-Daim MM
Environ Sci Pollut Res Int; 2020 Apr; 27(11):11461-11483. PubMed ID: 32072427
[TBL] [Abstract][Full Text] [Related]
8. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Fernández-Ruiz J; Sagredo O; Pazos MR; García C; Pertwee R; Mechoulam R; Martínez-Orgado J
Br J Clin Pharmacol; 2013 Feb; 75(2):323-33. PubMed ID: 22625422
[TBL] [Abstract][Full Text] [Related]
9. Pathways of cellular proteostasis in aging and disease.
Klaips CL; Jayaraj GG; Hartl FU
J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
[TBL] [Abstract][Full Text] [Related]
10. Proteostasis Disturbances and Inflammation in Neurodegenerative Diseases.
Sonninen TM; Goldsteins G; Laham-Karam N; Koistinaho J; Lehtonen Š
Cells; 2020 Sep; 9(10):. PubMed ID: 32998318
[TBL] [Abstract][Full Text] [Related]
11. Effects of cannabidiol (CBD) in neuropsychiatric disorders: A review of pre-clinical and clinical findings.
Elsaid S; Kloiber S; Le Foll B
Prog Mol Biol Transl Sci; 2019; 167():25-75. PubMed ID: 31601406
[TBL] [Abstract][Full Text] [Related]
12. Alzheimer's disease, aging, and cannabidiol treatment: a promising path to promote brain health and delay aging.
Liu Y
Mol Biol Rep; 2024 Jan; 51(1):121. PubMed ID: 38227160
[TBL] [Abstract][Full Text] [Related]
13. Cannabidiol: a promising drug for neurodegenerative disorders?
Iuvone T; Esposito G; De Filippis D; Scuderi C; Steardo L
CNS Neurosci Ther; 2009; 15(1):65-75. PubMed ID: 19228180
[TBL] [Abstract][Full Text] [Related]
14. Biological bases for a possible effect of cannabidiol in Parkinson's disease.
Ferreira-Junior NC; Campos AC; Guimarães FS; Del-Bel E; Zimmermann PMDR; Brum Junior L; Hallak JE; Crippa JA; Zuardi AW
Braz J Psychiatry; 2020 Apr; 42(2):218-224. PubMed ID: 31314869
[TBL] [Abstract][Full Text] [Related]
15. Karyopherin abnormalities in neurodegenerative proteinopathies.
Pasha T; Zatorska A; Sharipov D; Rogelj B; Hortobágyi T; Hirth F
Brain; 2021 Nov; 144(10):2915-2932. PubMed ID: 34019093
[TBL] [Abstract][Full Text] [Related]
16. Emerging Therapeutic Potential of Cannabidiol (CBD) in Neurological Disorders: A Comprehensive Review.
Singh K; Bhushan B; Chanchal DK; Sharma SK; Rani K; Yadav MK; Porwal P; Kumar S; Sharma A; Virmani T; Kumar G; Noman AA
Behav Neurol; 2023; 2023():8825358. PubMed ID: 37868743
[TBL] [Abstract][Full Text] [Related]
17. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Oxidative Stress and Neuroinflammation by Cannabidiol (CBD): Promising Targets for the Treatment of Alzheimer's Disease.
Hickey JP; Collins AE; Nelson ML; Chen H; Kalisch BE
Curr Issues Mol Biol; 2024 May; 46(5):4379-4402. PubMed ID: 38785534
[TBL] [Abstract][Full Text] [Related]
19. Is cannabidiol the ideal drug to treat non-motor Parkinson's disease symptoms?
Crippa JAS; Hallak JEC; Zuardi AW; Guimarães FS; Tumas V; Dos Santos RG
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):121-133. PubMed ID: 30706171
[TBL] [Abstract][Full Text] [Related]
20. Proteinopathies, a core concept for understanding and ultimately treating degenerative disorders?
Bayer TA
Eur Neuropsychopharmacol; 2015 May; 25(5):713-24. PubMed ID: 23642796
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
